Active ingredients
Pharmacological Group
Used in the treatment
- J38.1 Polyp of vocal cord and larynx
- G05.2 Encephalitis, myelitis and encephalomyelitis in other infectious and parasitic diseases classified elsewhere
- G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified
- D76.0 Langerhans' cell histiocytosis, not elsewhere classified
- G05.8 Encephalitis, myelitis and encephalomyelitis in other diseases classified elsewhere
- G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
- D23.9 Benign neoplasm, skin, unspecified
- C46.9 Kaposi's sarcoma, unspecified
- B30.9 Viral conjunctivitis, unspecified